Anika Therapeutics, Inc. (ANIK) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 137.8M |
| Enterprise Value | 106.56M |
| P/E Ratio | -79.48 |
| PEG Ratio | -0.28 |
| Price/Sales Ratio | 2.38 |
| Price/Book Ratio | 2.1 |
| Enterprise/Revenue | 2.25 |
| Enterprise/EBITDA | 99.95 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -0.03 |
| Operating Margin | -0.04 |
| Return On Assets | -0.02 |
| Return On Equity | -0.03 |
| Revenue | 112.82M |
| Revenue/Share | 8.98 |
| Gross Profit | 63.81M |
| EBITDA | -3.58M |
| Net Income | -10.88M |
| Diluted EPS | -0.76 |
| Total Cash | 38.41M |
| Total Cash/Share | 2.86 |
| Total Debt | 23.32M |
| Total Debt/Equity | 0.17 |
| Current Ratio | 4.48 |
| Book Value Per Share | 10.22 |
| 52-Week Change | 160.9 |
| 52-Week High | 21.55 |
| 52-Week Low | 7.92 |
| Moving Average 50 Days | 15.69 |
| Moving Average 200 Days | 12.8 |
| Average Volume | 81,462 |
| Shares Outstanding | 13.38M |
| % Held by Institutions | 86.19 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |